Department of Endocrinology, The Second Hospital of Jilin University, Changchun 130041, P.R. China.
Jilin Provincial Key Laboratory for Molecular and Chemical Genetics, The Second Hospital of Jilin University, Changchun 130041, P.R. China.
Aging (Albany NY). 2023 Jun 29;15(12):5917-5950. doi: 10.18632/aging.204847.
Depression and obesity are both common disorders currently affecting public health, frequently occurring simultaneously within individuals, and the relationship between these disorders is bidirectional. The association between obesity and depression is highly co-morbid and tends to significantly exacerbate metabolic and related depressive symptoms. However, the neural mechanism under the mutual control of obesity and depression is largely inscrutable. This review focuses particularly on alterations in systems that may mechanistically explain the homeostatic regulation of the obesity and depression link, such as immune-inflammatory activation, gut microbiota, neuroplasticity, HPA axis dysregulation as well as neuroendocrine regulators of energy metabolism including adipocytokines and lipokines. In addition, the review summarizes potential and future treatments for obesity and depression and raises several questions that need to be answered in future research. This review will provide a comprehensive description and localization of the biological connection between obesity and depression to better understand the co-morbidity of obesity and depression.
抑郁和肥胖都是目前影响公众健康的常见疾病,它们经常同时在个体中发生,并且这两种疾病之间存在双向关系。肥胖和抑郁之间的关联高度共病,往往会显著加重代谢和相关的抑郁症状。然而,肥胖和抑郁相互控制下的神经机制在很大程度上仍难以理解。本综述特别关注可能从机制上解释肥胖和抑郁关联的内稳态调节的系统改变,例如免疫炎症激活、肠道微生物群、神经可塑性、HPA 轴失调以及包括脂肪细胞因子和脂因子在内的能量代谢神经内分泌调节剂。此外,该综述总结了肥胖和抑郁的潜在和未来治疗方法,并提出了未来研究中需要回答的几个问题。本综述将全面描述和定位肥胖和抑郁之间的生物学联系,以更好地理解肥胖和抑郁的共病现象。